Latest Licensing News

Cobalt Blue Holdings and Glomar Minerals have teamed up to develop a pioneering polymetallic nodule processing facility in the US, aiming to secure critical minerals for advanced manufacturing and defence sectors.

Kjerulf David Hastings Ainsworth has initiated a second unconditional off-market takeover bid for 5.5% of Ainsworth Game Technology shares at a significant premium, aiming to increase his stake and influence in the company.

Temas Resources has formed a Scientific Advisory Board of hydrometallurgical leaders to accelerate the rollout of its innovative Regenerative Chloride Leaching technology, promising major cost and environmental benefits in critical minerals processing.

Firebrick Pharma has secured its first regulatory approval for Nasodine Nasal Spray in Indonesia, paving the way for entry into Southeast Asia’s largest market. This milestone marks a significant step in the company’s international expansion strategy.

InFocus Group Holdings has completed Codexa, a proprietary sweepstakes casino platform targeting the booming US market, with plans for licensing and potential sale.

Global Laser Enrichment has secured a US$98.9 million incentives package from Kentucky authorities to advance the Paducah Laser Enrichment Facility, marking a major milestone in the US nuclear fuel cycle. This support, alongside a US$28.5 million Department of Energy award, underlines the growing momentum behind Silex Systems’ laser uranium enrichment technology.

Weebit Nano has launched a significant A$80 million institutional placement, alongside additional funding initiatives, to accelerate its ReRAM technology leadership and broaden AI-related offerings.

PainChek has reported a strong quarter in the UK aged care sector, securing 4,000 new licenses and driving 9% quarter-on-quarter growth, signalling rising demand for its AI-driven pain assessment technology.

Eve Health Group is advancing its proprietary reformulation platform with two fast-onset products launched under Australia's SAS-B pathway, targeting large underserved markets in women's and men's health. The company’s capital-light, partner-led model aims for rapid revenue growth post-ARTG registration.

Atomo Diagnostics has responded to an ASX price query following unusual trading activity, denying any undisclosed price-sensitive information while acknowledging a related FDA update involving Lumos Diagnostics.

Variscan Mines’ Scoping Study for the San José Mine restart in Spain reveals strong economics, low upfront capital, and an 11-year mine life, setting the stage for zinc and lead production from 2028.

Nickel Industries has secured a significant increase in its 2026 ore sales license and finalized a long-term supply agreement for its Excelsior Nickel Cobalt project, enhancing production certainty and sustainability.